Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • In Brief
  • Published:

Stroke

Steroids may improve outcome in acute hemorrhagic stroke

Nature Reviews Neurology volume 8, page 4 (2012)Cite this article

Subjects

Access through your institution
Buy or subscribe

A new two-center study provides support for the use of intravenous dexamethasone in patients with acute hemorrhagic stroke—a treatment strategy that is employed routinely at the University Hospital of Heraklion, Crete but has not been widely adopted elsewhere. Patients with acute hemorrhagic stroke who were treated in Heraklion (391 cases, 341 of whom received intravenous dexamethasone) had better outcomes than those treated at Massachusetts General Hospital, Boston, USA (510 cases, none of whom received corticosteroids).

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

ORIGINAL RESEARCH PAPER

  1. Zaganas, I. et al. A comparison of acute hemorrhagic stroke outcomes in 2 populations: the Crete–Boston Study. Stroke doi:10.1161/STROKEAHA.111.632174

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steroids may improve outcome in acute hemorrhagic stroke. Nat Rev Neurol 8, 4 (2012). https://doi.org/10.1038/nrneurol.2011.210

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrneurol.2011.210

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing